FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048542517> ?p ?o ?g. }

• W3048542517 endingPage "256" @default.
• W3048542517 startingPage "249" @default.
• W3048542517 abstract "•Acute pUEDVT treatment with thrombolysis, TOD and immediate PTA is effective. •The anatomic substrate and residual lesions can be treated in the same admission. •Follow-up shows good functional outcome, high quality of life and return to work. Background Multiple algorithms exist for treating acute primary upper extremity deep venous thrombosis (pUEDVT) caused by venous thoracic outlet syndrome (VTOS). In this case series, we present the results of our dedicated same admission treatment algorithm. Methods All patients between January 2015 and December 2019 with an established acute upper extremity deep venous thrombosis (symptoms <14 days) caused by VTOS were treated according to an algorithm consisting of same admission thrombolysis, transaxillary thoracic outlet decompression (TA-TOD) with extensive venolysis, and venography. If a residual stenosis of the subclavian vein was identified on venography, including by means of low-pressure diagnostic balloon inflation, correction by percutaneous transluminal angioplasty (PTA) was performed. The thoracic outlet syndrome disability scale, the Dutch language version of the disabilities of the arm, shoulder, and hand, and the VEINES–quality of life (VEINES-QOL/VEINES-symptoms) questionnaires were collected during follow-up. Results In total, 10 patients were treated for acute pUEDVT. After successful thrombolysis (100%) and TA-TOD, immediate venography showed residual stenosis of the subclavian vein in 8 of 10 patients (80%). Low-pressure dilatation of a balloon suited to the geometry of the axillosubclavian vein showed significant tapering in all cases (10/10) after which a formal venous PTA was performed. No stents were used. Mean time to discharge was 6.4 days. All patients were free of symptoms at a mean follow-up period of 34.4 months. Eight of the 10 patients completed follow-up questionnaires and reported a mean thoracic outlet syndrome disability scale of 0.6, mean disabilities of the arm, shoulder, and hand score of 4.2, and a median VEINES-Symptoms of 55.23 (IQR, 12.13), and VEINES-QOL of 55.29 (IQR, 15.42). Conclusions A same admission treatment algorithm for acute pUEDVT in patients with VTOS including thrombolysis, TA-TOD with extensive venolysis, and immediate venography with PTA is effective with promising intermediate results. Multiple algorithms exist for treating acute primary upper extremity deep venous thrombosis (pUEDVT) caused by venous thoracic outlet syndrome (VTOS). In this case series, we present the results of our dedicated same admission treatment algorithm. All patients between January 2015 and December 2019 with an established acute upper extremity deep venous thrombosis (symptoms <14 days) caused by VTOS were treated according to an algorithm consisting of same admission thrombolysis, transaxillary thoracic outlet decompression (TA-TOD) with extensive venolysis, and venography. If a residual stenosis of the subclavian vein was identified on venography, including by means of low-pressure diagnostic balloon inflation, correction by percutaneous transluminal angioplasty (PTA) was performed. The thoracic outlet syndrome disability scale, the Dutch language version of the disabilities of the arm, shoulder, and hand, and the VEINES–quality of life (VEINES-QOL/VEINES-symptoms) questionnaires were collected during follow-up. In total, 10 patients were treated for acute pUEDVT. After successful thrombolysis (100%) and TA-TOD, immediate venography showed residual stenosis of the subclavian vein in 8 of 10 patients (80%). Low-pressure dilatation of a balloon suited to the geometry of the axillosubclavian vein showed significant tapering in all cases (10/10) after which a formal venous PTA was performed. No stents were used. Mean time to discharge was 6.4 days. All patients were free of symptoms at a mean follow-up period of 34.4 months. Eight of the 10 patients completed follow-up questionnaires and reported a mean thoracic outlet syndrome disability scale of 0.6, mean disabilities of the arm, shoulder, and hand score of 4.2, and a median VEINES-Symptoms of 55.23 (IQR, 12.13), and VEINES-QOL of 55.29 (IQR, 15.42). A same admission treatment algorithm for acute pUEDVT in patients with VTOS including thrombolysis, TA-TOD with extensive venolysis, and immediate venography with PTA is effective with promising intermediate results." @default.
• W3048542517 created "2020-08-18" @default.
• W3048542517 creator A5016351065 @default.
• W3048542517 creator A5016723143 @default.
• W3048542517 creator A5040049504 @default.
• W3048542517 creator A5055241360 @default.
• W3048542517 creator A5074315102 @default.
• W3048542517 creator A5080831068 @default.
• W3048542517 creator A5086630480 @default.
• W3048542517 date "2021-02-01" @default.
• W3048542517 modified "2023-10-16" @default.
• W3048542517 title "Same Admission Hybrid Treatment of Primary Upper Extremity Deep Venous Thrombosis with Thrombolysis, Transaxillary Thoracic Outlet Decompression, and Immediate Endovascular Evaluation" @default.
• W3048542517 cites W1891547992 @default.
• W3048542517 cites W1963842191 @default.
• W3048542517 cites W1965821124 @default.
• W3048542517 cites W1977680266 @default.
• W3048542517 cites W1990325882 @default.
• W3048542517 cites W2008793728 @default.
• W3048542517 cites W2020484175 @default.
• W3048542517 cites W2036903708 @default.
• W3048542517 cites W2040215110 @default.
• W3048542517 cites W2067127724 @default.
• W3048542517 cites W2069600753 @default.
• W3048542517 cites W2074062192 @default.
• W3048542517 cites W2082859625 @default.
• W3048542517 cites W2084486727 @default.
• W3048542517 cites W2089235231 @default.
• W3048542517 cites W2089832700 @default.
• W3048542517 cites W2101056181 @default.
• W3048542517 cites W2101732233 @default.
• W3048542517 cites W2123767185 @default.
• W3048542517 cites W2130010985 @default.
• W3048542517 cites W2143670080 @default.
• W3048542517 cites W2160575948 @default.
• W3048542517 cites W2165370865 @default.
• W3048542517 cites W2168460878 @default.
• W3048542517 cites W2225937646 @default.
• W3048542517 cites W2338023964 @default.
• W3048542517 cites W2516613092 @default.
• W3048542517 cites W2520385359 @default.
• W3048542517 cites W2602020159 @default.
• W3048542517 cites W2964013370 @default.
• W3048542517 cites W2969320705 @default.
• W3048542517 cites W2994733005 @default.
• W3048542517 cites W3004612052 @default.
• W3048542517 cites W4231282746 @default.
• W3048542517 cites W4244582674 @default.
• W3048542517 doi "https://doi.org/10.1016/j.avsg.2020.07.052" @default.
• W3048542517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32795648" @default.
• W3048542517 hasPublicationYear "2021" @default.
• W3048542517 type Work @default.
• W3048542517 sameAs 3048542517 @default.
• W3048542517 citedByCount "4" @default.
• W3048542517 countsByYear W30485425172022 @default.
• W3048542517 countsByYear W30485425172023 @default.
• W3048542517 crossrefType "journal-article" @default.
• W3048542517 hasAuthorship W3048542517A5016351065 @default.
• W3048542517 hasAuthorship W3048542517A5016723143 @default.
• W3048542517 hasAuthorship W3048542517A5040049504 @default.
• W3048542517 hasAuthorship W3048542517A5055241360 @default.
• W3048542517 hasAuthorship W3048542517A5074315102 @default.
• W3048542517 hasAuthorship W3048542517A5080831068 @default.
• W3048542517 hasAuthorship W3048542517A5086630480 @default.
• W3048542517 hasBestOaLocation W30485425172 @default.
• W3048542517 hasConcept C126322002 @default.
• W3048542517 hasConcept C126838900 @default.
• W3048542517 hasConcept C139059822 @default.
• W3048542517 hasConcept C141071460 @default.
• W3048542517 hasConcept C2775836813 @default.
• W3048542517 hasConcept C2778269268 @default.
• W3048542517 hasConcept C2778959117 @default.
• W3048542517 hasConcept C2779581417 @default.
• W3048542517 hasConcept C2780011451 @default.
• W3048542517 hasConcept C2780548207 @default.
• W3048542517 hasConcept C2780813298 @default.
• W3048542517 hasConcept C2780868729 @default.
• W3048542517 hasConcept C2781267111 @default.
• W3048542517 hasConcept C2909104349 @default.
• W3048542517 hasConcept C500558357 @default.
• W3048542517 hasConcept C71924100 @default.
• W3048542517 hasConceptScore W3048542517C126322002 @default.
• W3048542517 hasConceptScore W3048542517C126838900 @default.
• W3048542517 hasConceptScore W3048542517C139059822 @default.
• W3048542517 hasConceptScore W3048542517C141071460 @default.
• W3048542517 hasConceptScore W3048542517C2775836813 @default.
• W3048542517 hasConceptScore W3048542517C2778269268 @default.
• W3048542517 hasConceptScore W3048542517C2778959117 @default.
• W3048542517 hasConceptScore W3048542517C2779581417 @default.
• W3048542517 hasConceptScore W3048542517C2780011451 @default.
• W3048542517 hasConceptScore W3048542517C2780548207 @default.
• W3048542517 hasConceptScore W3048542517C2780813298 @default.
• W3048542517 hasConceptScore W3048542517C2780868729 @default.
• W3048542517 hasConceptScore W3048542517C2781267111 @default.
• W3048542517 hasConceptScore W3048542517C2909104349 @default.
• W3048542517 hasConceptScore W3048542517C500558357 @default.
• W3048542517 hasConceptScore W3048542517C71924100 @default.
• W3048542517 hasLocation W30485425171 @default.
• W3048542517 hasLocation W30485425172 @default.

• next